Subscribe to RSS
DOI: 10.1055/s-0040-1704287
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA
Publication History
Publication Date:
23 April 2020 (online)
Aims EUS-RFA effectiveness and safety to induce syndrome relief in functioning neuroendocrine tumors(F-NETs) at high surgical risk (HSR)
Methods A19-G needle(EUSRA;STARmedCo,Korea) with 5 mm-monopolar electrode, inserted in a linear therapeutic EUS-scope and connected to RFA-generator and a peristaltic pump (infusing cold saline) delivered RFA.
Results 84years-old male at HSR with a 13-mm pancreatic tail symptomatic insulinoma was treated. 4subsequent RFA applications(12-16-12-10 seconds) at 30Watts (stop if impedance >500Ω) in 1endoscopic session were applied without complications with immediate syndrome relief. 3months-EUS showed a total not-vascularized area. Patient is still asymptomatic.
Conclusions EUS-RFA is a useful and safe option for F-NETs at HSR.
#